NEW YORK (TheStreet) -- When it comes to college savings, Americans are really counting on friends and family to meet their child's tuition needs.
In fact, 61% of Americans expect friends and family members to contribute to college funds for a son or daughter, according to Fidelity Investments.
In addition, 19% of parents want their closest friends and family members to forgo a traditional holiday gift this year and instead contribute to a college fund such as a college 529 plan.
Also see: 5 Year-End Tax Tips For Charitable Donations>>
Parents need the help, as only 34% of U.S. families are on track to cover their college savings costs. Cash gifts around the holidays could add some much-needed fuel to those college plans -- if families can convince their loved ones to pony up some cash come Christmas Day. "Contributing to a child's college savings fund is easy to do, and a gift more valuable to their future than anything you can buy in a mall," says Keith Bernhardt, vice president of college planning at Fidelity. "With many families still far behind their savings goals, monetary gifts can add up over time and make a difference in the years to come." Bernhardt says families with children of any age -- from newborns to those getting ready to head to campus -- can open a 529 in a child's name and manage how the savings are used for higher education expenses. "For parents making gifts to their own child's 529 account, direct deposit is a reliable way to help ensure savings are consistently contributed. Friends and family wanting to gift to a child's 529 account can give money to the parents, specifying it's for their college savings."
Also see: Young Families Only Think They Have a Handle on Holiday Spending>> So what's in it for the gift giver? No doubt the feel of good will knowing that a college funding contribution will help the college student earn his or her diploma is a big factor. Besides the "warm and fuzzy factor," Fidelity says, a college funding gift this holiday means one less trip to the mall and certainly no assembly or rush shipping.
Best of all, it's one gift unlikely to be returned.
Hot Gold Companies To Own In Right Now: Calamos Asset Management Inc.(CLMS)
Calamos Asset Management Inc. is a publicly owned investment manager. The firm provides investment advisory services to individuals including high net worth individuals, and institutions. It also manages accounts for family offices and private foundations. The firm manages separate client-focused equity and fixed income for its clients. It also launches and manages equity, fixed income, and balanced mutual funds for its clients. The firm invests in the public equity and fixed income markets across the globe. It also invests in alternative investments markets. The firm primarily invests in growth stocks of large-cap, mid-cap, and small-cap companies to make its investments. For fixed income, it invests in high yield bonds. The firm employs qualitative and fundamental analysis with a top-down and bottom-up stock picking approach to make its investments. It benchmarks the performance of its equity portfolios against the MSCI Indices, Russell Indices, and S&P 500 Index and its fixed income investments against the BofA Merrill Lynch Global 300 Convertible Index, BofA Merrill Lynch All U.S. Convertibles Ex-Mandatory Index, and CS High Yield Index. Calamos Asset Management Inc. was founded in 1977 and is based in Naperville, Illinois.
Advisors' Opinion:- [By GuruFocus]
Director Eric Singer sold 343,410 shares of SIGM stock on 12/20/2013 at the average price of 5.5. Eric Singer owns at least 464,499 shares after this. The price of the stock has decreased by 15.45% since.
Calamos Asset Management, Inc. (CLMS): Chairman, CEO & Global Co-CIO, 10% Owner John P Sr Calamos Bought 74,505 SharesChairman, CEO & Global Co-CIO, 10% Owner of Calamos Asset Management, Inc. (CLMS) John P Sr Calamos bought 74,505 shares during the past week at an average price of $11.99. Calamos Asset Management, Inc., is a global asset management firm that offers strategies to fulfill a range of asset allocation goals through a multi-team platform. Calamos Asset Management, Inc. has a market cap of $245.547 million; its shares were traded at around $11.99 with a P/E ratio of 20.20 and P/S ratio of 0.88. The dividend yield of Calamos Asset Management, Inc. stocks is 4.18%.
- [By GuruFocus]
Calamos Asset Management, Inc. (CLMS): Chairman, CEO & Global Co-CIO, 10% Owner John P Sr Calamos Bought 82,233 Shares
Chairman, CEO & Global Co-CIO, 10% Owner of Calamos Asset Management, Inc. (CLMS) John P Sr Calamos bought 82,233 shares during the past week at an average price of $11.50. Calamos Asset Management, Inc., is a global asset management firm that offers strategies to fulfill a range of asset allocation goals through a multi-team platform. Calamos Asset Management, Inc. has a market cap of $235.487 million; its shares were traded at around $11.50 with a P/E ratio of 19.20 and P/S ratio of 0.85. The dividend yield of Calamos Asset Management, Inc. stocks is 4.36%.
- [By David Sterman]
Calamos is in the process of shifting resources away from poorly performing funds and toward higher-performing ones. Recent signs are promising, though it appears as though the firm's founder is the only believer in this turnaround thus far.
Top 5 Shipping Stocks To Invest In 2014: TCW Strategic Income Fund Inc (TSI)
TCW Strategic Income Fund, Inc. (the Fund), formerly TCW Convertible Securities Fund, Inc., incorporated on January 13, 1987, is a diversified closed-end investment management company. The Fund's investment objective is to seek a total return consisting of current income and capital appreciation by investing in convertible securities, marketable equity securities, investment-grade debt securities, high-yield debt securities, options, and securities issued or guaranteed by the United States Government, its agencies and instrumentalities (U.S. Government Securities). The Fund also invests in repurchase agreements, mortgage-related securities, asset-backed securities, money market securities and other securities.
The Fund may invest in repurchase agreements secured by U.S. Government Securities. The Fund invests in sectors, such as financial services, aerospace and defense, airlines, automobiles, banking, commercial services, electric utilities, insurance, media, utilities, biotechnology and chemicals. The Fund�� investment advisor is TCW Investment Management Company.
Advisors' Opinion:- [By Dividends4Life]
According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund�� market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer
Top 5 Shipping Stocks To Invest In 2014: Ritchie Bros. Auctioneers Incorporated(RBA)
Ritchie Bros. Auctioneers Incorporated, an industrial auctioneer, sells various equipment to on-site and online bidders. The company, through unreserved public auctions, sells a range of used and unused industrial assets, including equipment, trucks, and other assets utilized in the construction, transportation, agricultural, material handling, mining, forestry, petroleum, and marine industries. It also provides Internet bidding services, which facilitate customers access to live and online auction participation. The company primarily serves buyers and sellers of equipment, trucks, and other industrial assets; rental companies and brokers; finance companies; and truck and equipment dealers. As of December 31, 2011, it operated approximately 110 locations in approximately 25 countries, including 43 auction sites worldwide. The company was founded in 1963 and is headquartered in Burnaby, Canada.
Advisors' Opinion:- [By Chris Hill]
Caterpillar's (NYSE: CAT ) �first-quarter profit�fell 45% and the company lowered guidance. But its CEO said that his confidence is at a two-year high and sales in China rose. Should investors buy the stock? In this installment, our analysts discuss Caterpillar's future and explain why Ritchie Bros. Auctioneers (NYSE: RBA ) could be a hidden winner.
- [By Canadian Value]
Australians will remember 2013 in part for the fall of some of our national corporate icons. The Ford Falcon and Holden Commodore are unlikely to be produced domestically going forward, and Qantas has unsuccessfully sought subsidies from the Federal government. Due to elevated cost structures and a high exchange rate, Australia Inc. is increasingly unable to compete in a fiercely competitive global market.High on the Reserve Bank of Australia�� (RBA) Christmas wish-list this year will be a lower exchange rate and a business community more willing to loosen its purse strings in 2014. Unfortunately, the first wish will likely need to be granted before the second can be realized. We expect the RBA will need to keep policy accommodative over the cyclical horizon and 2014 will be a critical transition year for the Australian economy.Over the year through September 2013, real growth in business investment outside the mining sector slowed to almost zero (0.5% to be precise, as shown in Figure 1). Why has Australia Inc. invested so little into its businesses this year? As RBA Deputy Governor Philip Lowe commented in a speech in late October, the lack of business investment in recent years is actually a global phenomenon across the developed world.�Although hard to quantify, this ��nvestment drought,��as Lowe described it, has likely been influenced by a lingering risk aversion after the financial crisis as well as the political uncertainty that has been common in many developed countries over the past few years. But in Australia another variable has also been restraining non-mining capital expenditure, and that is the elevated exchange rate.As Figure 1 shows, changes in the real trade-weighted exchange rate have historically led changes in non-mining business investment. As the real exchange rate appreciates, domestic products and services become less competitive relative to foreign goods and services, both at home and abroad. And of course, the reverse is true w
Top 5 Shipping Stocks To Invest In 2014: United Therapeutics Corporation(UTHR)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. It offers Remodulin, Tyvaso, and Adcirca for the treatment of pulmonary arterial hypertension (PAH). The company also develops Oral Treprostinil (UT-15C), a new drug application filed with the United States Food and Drug Administration for the treatment of PAH. Its development products under Phase III clinical trials include Oral Treprostinil (UT-15C) Combination Therapy for PAH; Ch14.18 monoclonal antibody (MAb) targeting Neuroblastoma; and Remodulin for the treatment of PAH in the United States, the United Kingdom, France, Germany, Italy, and Japan. The company?s development products under Phase I clinical trials comprise Beraprost-MR for PAH in North America, Europe, Mexico, South America, Egypt, India, South Africa, and Australia; 8H9 MAb targ eting Metastatic brain cancer; and IW001 for the treatment of Idiopathic pulmonary fibrosis and primary graft dysfunction. Its pre-clinical stage products consist of Glycobiology Antiviral Agents for viral infectious diseases; PLacental eXpanded cells targeting PAH; and pulmonary tissue replacement and remodeling products for the treatment of end-stage lung disease. The company serves pharmaceutical wholesalers through specialty pharmaceutical distributors and other distributors. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
Advisors' Opinion:- [By John Udovich]
The biotech sector may have lost some favor on Wall Street, but there is still plenty of interesting or overlooked news about the sector and/or biotech stocks like InterMune Inc (NASDAQ: ITMN), Biogen Idec Inc (NASDAQ: BIIB), Alexion Pharmaceuticals, Inc (NASDAQ: ALXN), United Therapeutics Corporation (NASDAQ: UTHR) and TNI BioTech, Inc (OTCMKTS: TNIB):
- [By Monica Gerson]
United Therapeutics (NASDAQ: UTHR) shares reached a new 52-week high of $91.13. United Therapeutics' PEG ratio is 1.64.
DENTSPLY International (NASDAQ: XRAY) shares touched a new 52-week high of $47.65. DENTSPLY's trailing-twelve-month ROE is 15.95%.
- [By Life Sciences Report]
AF: On the large-cap side, we like United Therapeutics Corp. (UTHR) and Vertex Pharmaceuticals Inc. (VRTX). United Therapeutics, in particular, has fallen out of favor somewhat, especially relative to the level of investor interest in the name 5-6 years back. Institutional holders have shifted from a largely biotech specialist group to a mix of value and generalist stocks. The upshot is that incremental buying on the part of healthcare specialists, as they re-engage with the name, ought to have a very positive impact on United Therapeutics' share price.